Cookson Peirce & Co’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,017
| Closed | -$232K | – | 291 |
|
|
2024
Q3 | $232K | Sell |
2,017
-13,037
| -87% | -$1.5M | 0.01% | 235 |
|
|
2024
Q2 | $2.07M | Sell |
15,054
-67
| -0.4% | -$9.22K | 0.1% | 80 |
|
|
2024
Q1 | $2.09M | Buy |
15,121
+3,932
| +35% | +$542K | 0.11% | 77 |
|
|
2023
Q4 | $1.47M | Sell |
11,189
-305
| -3% | -$40.2K | 0.09% | 86 |
|
|
2023
Q3 | $1.29M | Buy |
+11,494
| New | +$1.29M | 0.08% | 96 |
|
|
2023
Q1 | – | Sell |
-11,025
| Closed | -$1.32M | – | 245 |
|
|
2022
Q4 | $1.32M | Sell |
11,025
-379
| -3% | -$45.3K | 0.09% | 89 |
|
|
2022
Q3 | $1.21M | Buy |
+11,404
| New | +$1.21M | 0.09% | 94 |
|
|
2020
Q1 | – | Sell |
-12,023
| Closed | -$1.29M | – | 159 |
|
|
2019
Q4 | $1.29M | Buy |
12,023
+6,193
| +106% | +$666K | 0.11% | 85 |
|
|
2019
Q3 | $525K | Buy |
+5,830
| New | +$525K | 0.05% | 115 |
|